Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/23/2005EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor
03/23/2005EP1516619A2 Treatment of spasticity, convulsions by isovaleric acid derivatives CNS depressants
03/23/2005EP1516618A1 Coenzyme Q10 as antiapoptotic agent
03/23/2005EP1516617A2 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells
03/23/2005EP1516614A1 Method of preparing particles for agglomeration
03/23/2005EP1516597A1 Drug eluting stent
03/23/2005EP1516542A1 Nutritional supplement to treat macular degeneration
03/23/2005EP1516540A1 Use of vitamin D compounds
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer
03/23/2005EP1515979A1 Condensed palatinose and method for producing the same
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
03/23/2005EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/23/2005EP1515974A2 Novel maxi-k channel blockers, methods of use and process for making the same
03/23/2005EP1515973A1 Porphyrin-polyamine conjugates for cancer therapy
03/23/2005EP1515972A1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity
03/23/2005EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
03/23/2005EP1515968A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
03/23/2005EP1515967A1 2-heteroaryl carboxamides
03/23/2005EP1515966A1 Hydroxy pyranone derivative and preparation method thereof
03/23/2005EP1515965A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
03/23/2005EP1515964A1 Substituted diaminopyrimidines
03/23/2005EP1515961A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction
03/23/2005EP1515960A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515959A1 Pharmaceutical salts of reboxetine
03/23/2005EP1515956A1 Peptide deformylase inhibitors
03/23/2005EP1515955A2 Chemical process
03/23/2005EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
03/23/2005EP1515952A2 Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
03/23/2005EP1515949A1 Mitotic kinesin inhibitors
03/23/2005EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515942A1 Carboxamides derivatives
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1515926A2 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515751A1 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
03/23/2005EP1515750A1 Combinations comprising epothilones and pharmaceutical uses thereof
03/23/2005EP1515748A2 Anti-estrogen and immune modulator combinations for treating breast cancer
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
03/23/2005EP1515741A1 Composition comprising viscous fibers and viscosity-lowering proteins
03/23/2005EP1515736A1 Compositions against inflammatory processes
03/23/2005EP1515730A1 Novel maxi-k channel blockers, methods of use and process for making the same
03/23/2005EP1515729A1 Quaternised ammonium cyclodextrin compounds
03/23/2005EP1515728A2 Use of orally-available prostacyclin derivatives for the production of a medicament for the treatment of disease states associated with bone marrow oedema
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005EP1515725A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
03/23/2005EP1515724A1 Mitotic kinesin inhibitors
03/23/2005EP1515722A2 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515721A1 Ophthalmic compositions for treating ocular hypertension
03/23/2005EP1515720A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions
03/23/2005EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
03/23/2005EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids
03/23/2005EP1515717A1 Calcium salts of indole derived statins
03/23/2005EP1515716A2 Indole derivatives having anti-angiogenetic activity
03/23/2005EP1515714A1 Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field
03/23/2005EP1515713A1 Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents
03/23/2005EP1515712A2 Use of taurine for the treatment of alopecia
03/23/2005EP1515711A1 Pharmaceutical composition
03/23/2005EP1515710A1 Method of treating rosacea by topical application of a cyclohexane derivative
03/23/2005EP1515709A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder
03/23/2005EP1515708A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of depression
03/23/2005EP1515707A2 Method of treating atherosclerosis and other inflammatory diseases
03/23/2005EP1515705A1 Fluorosiloxane matrix controlled diffusion drug delivery system
03/23/2005EP1515704A1 Microcapsules for the delayed, controlled release of perindopril
03/23/2005EP1515703A1 Pharmaceutical compositions with improved dissolution
03/23/2005EP1515702A1 Abuse-protected administration form
03/23/2005EP1515701A1 Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
03/23/2005EP1515698A2 Liposomes containing biologically active compounds
03/23/2005EP1515697A1 Short duration depot formulations
03/23/2005EP1515695A1 Cosmetic or dermatological formulation for skincare after or before sunbathing or shaving
03/23/2005EP1515693A1 Soft solid antiperspirant with cooling and drying effect
03/23/2005EP1515687A2 Use of an agent inducing dopachrome tautomerase (trp-2) expression as protecting agent for hair follicle melanocytes and uses thereof
03/23/2005EP1515680A2 Use of thio-oxindole derivatives in treatment of skin disorders
03/23/2005EP1515674A1 Abuse-resistant opioid solid dosage form
03/23/2005EP1515607A2 Antimicrobial compositions, products and methods employing same
03/23/2005EP1404319A4 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
03/23/2005EP1383579B1 Composition, containing carnitine and huperzin for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
03/23/2005EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
03/23/2005EP1345618B1 Chlorzoxazone for the treatment of psoriasis
03/23/2005EP1335728B1 Medicament compositions based on tiotropium salts and on salmeterol salts
03/23/2005EP1328268B1 Combination of catechin and quercetin for pharmaceutical or dietary use
03/23/2005EP1322595A4 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
03/23/2005EP1309319B1 Pharmaceutical, effervescent formulation containing ramipril
03/23/2005EP1289977B1 Triterpenoid derivatives and their use as antiproliferative agents
03/23/2005EP1280795B1 N-substituted carbamoyloxyalkyl-azolium derivatives
03/23/2005EP1280528B1 R-eliprodil for treating glaucoma
03/23/2005EP1272218B1 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
03/23/2005EP1235566B1 Injectable valnemulin formulation
03/23/2005EP1228373B1 Diagnosis and therapy of cancer using sgp28-related molecules
03/23/2005EP1185623A4 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
03/23/2005EP1152764A4 Compositions and methods for use in targeting vascular destruction
03/23/2005EP1114166B1 Method for down-regulating osteoprotegerin ligand activity
03/23/2005EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
03/23/2005EP1100469B1 Rapidly disintegrable solid preparation
03/23/2005EP1098647B1 Compounds and compositions for treating tissue ischemia
03/23/2005EP1091924A4 Novel retinoids and use thereof
03/23/2005EP1089733B1 Use of optically pure (+)-norcisapride for treating irritable bowel syndrome
1 ... 4746 4747 4748 4749 4750 4751 4752 4753 4754 4755 4756 4757 4758 4759 4760 4761 4762 4763 4764 4765 4766 ... 7860